The purpose of the study was to compare serum level of folic acid (FA) in patients with erectile dysfunction (ED) versus healthy controls and to assess its correlation with other well-known confounders for ED.
Our prospective study compared FA in 60 patients with ED versus 30 healthy controls. Patients were excluded if they had any hormonal disorders, Peyronie’s disease, or decompensated systemic illnesses. ED was evaluated by the validated Arabic version of the abbreviated five-item form of the International Index Of Erectile Function and confirmed by penile duplex. Serum FA level was assayed using ELIZA. Mann–Whitney, Kruskal–Wallis, and Chi-square tests and Spearman correlation were used as appropriate and confirmed by logistic regression model.
Our study revealed that the median FA of the cases and the controls were 7.1 ng/mL and 13.4 ng/mL, respectively, and this difference was of high statistical significance (p < 0.001). Moreover, our study demonstrated significant relations between serum FA with DM, HTN, smoking, age, and cholesterol (p 0.01, 0.03, 0.014, 0.001, and 0.015, respectively). Our study showed that the best cut-off point of serum FA to detect patients with ED was found to be ≤ 9.42 with sensitivity of 80.00%, specificity of 93.33% and area under curve (AUC) of 91.3%.
Serum FA level decreased as the severity of ED increased even after adjustment of age, serum testosterone, DM, HTN, and smoking. FA deficiency might be an independent risk factor of ED.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Hatzimouratidis K, Giuliano F, Moncada I, Muneer A, Salonia A, Verze P (2016) Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation 62(3):543–552
Porst H (2009) Premature ejaculation. Urol A 48:663–674
Zhengyan T, Li D, Zhang X, Yi L, Zhu X, Zeng X, Tang Y (2014) Comparison of the simplified International Index of erectile function (IIEF-5) in patients of erectile dysfunction with different pathophysiologies. BMC Urol 14:52
Antonio A, Bruzziches R, Francomano D, Natali M, Gareri P, Spera G (2010) Endothelial dysfunction and erectile dysfunction in the aging man. Int J Urol 17:38–47
Zhongjian C, Yang X, Wang H (2010) Hyperhomocysteinemia and endothelial dysfunction. Curr Hypertens Rev 5(2):158–165
Yang HF, Kao TW, Lin YY et al (2017) Does serum homocysteine explain the connection between sexual frequency and cardiovascular risk? J Sex Med 14:910–917
Yan WJ, Yu N, Yin TL, Zou YJ, Yang J (2014) A new potential risk factor in patients with erectile dysfunction and premature ejaculation: folate deficiency. Asian J Androl 16:902–906
Hamidi Madani A, Asadolahzade A, Mokhtari G, Shahrokhi Damavand R, Farzan A, Esmaeili S (2013) Assessment of the efficacy of combination therapy with folic acid and tadalafil for the management of erectile dysfunction in men with type 2 diabetes mellitus. J Sex Med 10:1146–1150
Cui S, Li W, Lv X, Wang P, Gao Y, Huang G (2017) Folic acid supplementation delays atherosclerotic lesion development by modulating MCP1 and VEGF DNA methylation levels in vivo and in vitro. Int J Mol Sci 18(5):990
Shamloul R, Ghanem H, Abou-zeid A (2004) Validity of the Arabic version of the sexual health inventory for men among Egyptians. Int J Impot Res 16:452–455
Cappelleri JC, Rosen RC (2005) The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res 17:307–319
Karabakan M, Erkmen AE, Guzel O, Aktas BK, Bozkurt A, Akdemir S (2016) Association between serum folic acid level and erectile dysfunction. Andrologia 48:532–535
Inman BA, Sauver JL, Jacobson DJ, McGree ME, Nehra A, Lieber MM, Roger VL, Jacobsen SJ (2009) A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc 84(2):108–113
Neelam C, Singh NK, Banerjee BD, Bala K, Basu M, Sharma D (2014) Intergenotypic variation of vitamin B12 and folate in AD: in north indian population. Ann Indian Acad Neurol 17(3):308–312
Vardavas CI, Linardakis MK, Hatzis CM, Malliaraki M Saris WH, Kafatos AG (2008) Smoking status in relation to serum folate and dietary vitaminintake. Tob Induc Dis 4:8. https://doi.org/10.1186/1617-9625-4-8
Scazzone C, Bono A, Tornese F, Arsena R, Schillaci R, Buter D, Cottone S (2014) Correlation between low folate levels and hyperhomocysteinemia, but not with vitamin B12 in hypertensive patients. Ann Clin Lab Sci 44(3):286–290
Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274(13):1049–1057
Clarke R, Lewington S, Landray M (2003) Homocysteine, renal function, and risk of cardiovascular disease. Kidney Int 63:S131–S133
Cheng Z-J, Yang X, Wang H (2009) Hyperhomocysteinemia and endothelial dysfunction. Curr Hypertens Rev 5(2):158–165
Zhang Z, Xu Z, Dai Y, Chen Y (2017) Elevated serum homocysteine level as an independent risk factor for erectile dysfunction: a prospective pilot case-control study. Andrologia. https://doi.org/10.1111/and.12684
Sansone M, Sansone A, Romano M, Seraceno S, Di Luigi L, Romanelli F (2017) Folate: a possible role in erectile dysfuntion. Aging Male 21(2):116–120. https://doi.org/10.1080/13685538.2017.1404022
Pfanzagl B, Tribl F, Koller E, Möslinger T (2003) Homocysteine strongly enhances metal-catalyzed LDL oxidation in the presence of cystine and cysteine. Atherosclerosis 168:39–48
Qin X, Xu M, Zhang Y, Li J, Xu X, Wang X, Xu X, Huo Y (2012) Effect of folic acid supplementation on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials. Atherosclerosis 222:307–313
Ebesunun MO, Obajobi EO (2012) Elevated plasma homocysteine in type 2 diabetes mellitus: a risk factor for cardiovascular diseases. Pan Afr Med J 12:48
Kilicdag EB, Bagis T, Tarim E et al (2005) Administration of B group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial. Hum Reprod 20(6):1521–1528
Feng Y, Shan MQ, Bo L, Zhang XY, Hu J (2015) Association of homocysteine with type 1 diabetes mellitus: a metaanalysis. Int J Clin Exp Med 8(8):12529–12538
Sansone A, Cignarelli A, Sansone M, Romanelli F, Corona G, Gianfrilli D, Isidori A, Giorgino F, Lenzi A (2018) Serum homocysteine levels in men with and without erectile dysfunction: a systematic review and meta-analysis. Int J Endocrinol. https://doi.org/10.1155/2018/7424792
Mirone V, Imbimbo C, Bortolotti A et al (2002) Cigarette smoking as risk factor for erectile dysfunction: results from an Italian epidemiological study. Eur Urol 41(3):294–297
Lubin JH, Couper D, Lutsey PL, Yatsuya H (2017) Synergistic and non-synergistic associations for cigarette smoking and non-tobacco risk factors for cardiovascular disease incidence in the atherosclerosis risk in communities (ARIC) study. Nicotine Tob Res 19(7):826–835
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the local ethical committee.
Informed consent was obtained from all individual participants included in the study.
About this article
Cite this article
Attia, A.A.A., Amer, M.A.E.M., Hassan, M. et al. Low serum folic acid can be a potential independent risk factor for erectile dysfunction: a prospective case–control study. Int Urol Nephrol 51, 223–229 (2019). https://doi.org/10.1007/s11255-018-2055-y
- Erectile dysfunction
- Serum folic acid
- Severity of erectile dysfunction